Clinical Trial Update: Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy [Phase 1]

View source ↗

Summary

Phase 1 trial of F-627 in women with breast cancer receiving myelotoxic chemotherapy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Neutropenia

Drugs mentioned

• F-627

Snippet

Sponsor: EVIVE Biotechnology | Conditions: Neutropenia, Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-02-23